[Type 2 insulin-dependent diabetes: patient characteristics and effects of insulin therapy]

[Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes].

Revue medicale de Liege·2008

[Medication of the month. Rimonabant (Acomplia): first CB1 receptor antagonist of the endocannabinoid system].

Revue medicale de Liege·2008

[Isolated tricuspid valve endocarditis as a cause of fever of unknown origin].

Revue medicale de Liege·2008

[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge].

Revue medicale de Liege·2008

[Therapy of type 2 diabetes: between insulin sensitizers and insulin secreting agents].

Revue medicale de Liege·2008

[Aspirin resistance in diabetic patients: laboratory entity or clinical reality?].

Revue medicale de Liege·2007

[Major depressive episode with psychotic features and vitamin B12 deficiency : a neuropsychiatric interplay].

Revue medicale de Liege·2026

[Comparison of multidisciplinary spine rehabilitation programs for patients with chronic low back pain in French-speaking Belgium].

Revue medicale de Liege·2026

[Acute anterior ischemic optic neuropathy in the context of mitochondrial disease].

Revue medicale de Liege·2026

[Anaphylaxis to MMR vaccine gelatin : practical recommendations].

Revue medicale de Liege·2026

[Evaluation of the use of virtual reality hypnosis during Port-a-cath® placement in adult oncology patients as an effective alternative to intravenous sedation : a pilot study].

Revue medicale de Liege·2026

[Type 1 diabetes, towards new horizons].

Revue medicale de Liege·2026

Evolutionary dynamics and functional refinement of IGF bioavailability in the vertebrate phylum : focus on IGFBPs.

The Journal of endocrinology·2026

Analytical validation of an ELISA-based test kit for polymeric IgA immune complexes in IgA nephropathy.

Clinical nephrology·2026

STING-GDF15-STAT3 signaling contributes to neuroinflammation after intracerebral hemorrhage.

Experimental neurology·2026

Related Experiment Videos

[Type 2 insulin-dependent diabetes: patient characteristics and effects of insulin therapy]

Related Concept Videos

[Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes].

[Medication of the month. Rimonabant (Acomplia): first CB1 receptor antagonist of the endocannabinoid system].

[Isolated tricuspid valve endocarditis as a cause of fever of unknown origin].

[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge].

[Therapy of type 2 diabetes: between insulin sensitizers and insulin secreting agents].

[Aspirin resistance in diabetic patients: laboratory entity or clinical reality?].

[Major depressive episode with psychotic features and vitamin B12 deficiency : a neuropsychiatric interplay].

[Comparison of multidisciplinary spine rehabilitation programs for patients with chronic low back pain in French-speaking Belgium].

[Acute anterior ischemic optic neuropathy in the context of mitochondrial disease].

[Anaphylaxis to MMR vaccine gelatin : practical recommendations].

[Evaluation of the use of virtual reality hypnosis during Port-a-cath® placement in adult oncology patients as an effective alternative to intravenous sedation : a pilot study].

[Type 1 diabetes, towards new horizons].

Evolutionary dynamics and functional refinement of IGF bioavailability in the vertebrate phylum : focus on IGFBPs.

Analytical validation of an ELISA-based test kit for polymeric IgA immune complexes in IgA nephropathy.

STING-GDF15-STAT3 signaling contributes to neuroinflammation after intracerebral hemorrhage.

Related Experiment Videos

[Type 2 insulin-dependent diabetes: patient characteristics and effects of insulin therapy]

Related Concept Videos

Related Articles